Geron signals 2026 growth focus as RYTELO new patient starts rise to 36% in Q3 (NASDAQ:GERN)

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. ...